Drug Utilization Pattern of Proton Pump Inhibitors in Patients with Acid Peptic Disease and Comorbidities in India: A Real-World Electronic Medical Records-Based Study. [PDF]
Garje Y +11 more
europepmc +1 more source
A Critical Perspective on Helicobacter pylori Treatment Strategies: Are Levofloxacin-Based Regimens Truly Suitable as First-Line Therapy? [PDF]
Dertli R, Asil M.
europepmc +1 more source
Proton pump inhibitors and the risk of urolithiasis: A Mendelian randomization study. [PDF]
Guo J, Chen X, Dou Y, Xiong Y, Zhao T.
europepmc +1 more source
Efficacy and safety of Lanqin Oral Liquid combined with Western medicine for the treatment of pharyngitis: a systematic review and meta-analysis. [PDF]
Mu X, Luo Q, Yuan Y.
europepmc +1 more source
Bioequivalence of a single dose of two palbociclib formulations in healthy Chinese subjects under fasting conditions: a two-period crossover study with rabeprazole pre-treatment. [PDF]
Bai W +11 more
europepmc +1 more source
Including Vonoprazan With PPIs Challenges the Drug-Interaction Hypothesis. [PDF]
Shamsulddin AB.
europepmc +1 more source
Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]
Almabruk BA +8 more
europepmc +1 more source
Comparative efficacy, safety and compliance with dual, triple and quadruple therapy as the first-line treatment regimens for <i>Helicobacter pylori</i> eradication: a systematic review and network meta-analysis. [PDF]
Taufiqqurrachman I +6 more
europepmc +1 more source
Methotrexate toxicity due to a medication dispensing error compounded by an interaction with proton pump inhibitors. [PDF]
Chakrabarti A +4 more
europepmc +1 more source
A Vanished Association Between Proton Pump Inhibitors and Clostridioides Difficile Infection After Minimizing Bias. [PDF]
Wu B, He Z, Xu T.
europepmc +1 more source

